Article
MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
Clinical pharmacology and therapeutics - 1 Jan 2006
Meisel Peter, Giebel Jürgen, Kunert-Keil Christiane, Dazert Peter, Kroemer Heyo K, Kocher Thomas
Abstract excerpt
BACKGROUND: Gingival overgrowth is a common side effect of calcium antagonists. Although the pathogenesis is unknown, several lines of evidence point to a modulation of inflammatory processes. Because the calcium antagonists, albeit to a variable degree, act as inhibitors of P-glycoprotein (P-gp), the gene product of multidrug resistance 1 (MDR1), and inflammation may modify P-gp expression, we analyzed the MDR1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
